Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.306 M S Topp , M Stelljes , G Zugmaier , P Barnette , L T Heffner , T Trippett , J Duell , R C Bargou , C Holland , J E Benjamin , M Klinger , M R Litzow
Leukemia ( IF 12.8 ) Pub Date : , DOI: 10.1038/leu.2017.306 M S Topp , M Stelljes , G Zugmaier , P Barnette , L T Heffner , T Trippett , J Duell , R C Bargou , C Holland , J E Benjamin , M Klinger , M R Litzow
Blinatumomab retreatment after relapse in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia
中文翻译:
复发/难治性B前体急性淋巴细胞白血病患者复发后的Blinatumomab复治
复发/难治性B前体急性淋巴细胞白血病患者复发后的Blinatumomab复治
更新日期:2017-10-11
Leukemia, Published online: 9 October 2017; doi:10.1038/leu.2017.306
中文翻译:
复发/难治性B前体急性淋巴细胞白血病患者复发后的Blinatumomab复治
复发/难治性B前体急性淋巴细胞白血病患者复发后的Blinatumomab复治
白血病,在线发布:2017年10月9日; doi:10.1038 / leu.2017.306